Startup Mahzi Therapeutics targets autism, epilepsy related rare genetic brain disorders - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

United Kingdom News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

How former $RARE employees, academics, patient groups and VCs are targeting autism, epilepsy and other genetic brain disorders

The company has 10 employees.At the center of the disorder is a gene called"WW domain containing oxidoreductase," or WWOX, that encodes for a protein that plays a role in brain development. When that protein is deficient, it causes WOREE syndrome, or"WWOX-related epileptic encephalopathy."Children diagnosed with the extremely rare mutation can develop seizures that can't be treated by drugs — what's known as refractory epilepsy.

With its MZ-9138 program, Mahzi looks to change that prognosis for children with WOREE as well as those with a slightly less severe form which presents at around 10-12 months of age. Mahzi is making the vector, an adeno-associated virus, and will start investigational new drug studies once it is ready, Weiss said. It could be in the clinic in 2024.

Mahzi's patient foundation and academic collaborations also are clear with the other two programs it has disclosed on its website.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 78. in UK
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Rezo Therapeutics, Prosper Marketplace score $75M venture rounds - San Francisco Business TimesThe Thanksgiving holiday didn't stop a drug developer and an online lender from each raising a large new round.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »

San Francisco nonprofit developer HomeRise appoints Interim CEO, CFO - San Francisco Business TimesHomeRise, formerly Community Housing Partnership, oversees a portfolio of roughly 1,600 units in San Francisco and the Bay Area.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »

Rezo Therapeutics, Prosper Marketplace score $75M venture rounds - Silicon Valley Business JournalThe Thanksgiving holiday didn't stop a drug developer and an online lender from each raising a large new round.
Source: svbizjournal - 🏆 334. / 59 Read more »

Crypto startup MoonPay hires Time president to lead its enterprise businessTime president Keith Grossman is leaving the legacy publisher to take on a new role as the president of enterprise at crypto trading platform MoonPay.
Source: CNBC - 🏆 12. / 72 Read more »